SOLENO THERAPEUTICS INC Income Statement
SLNO / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
Revenue has declined at a 21.5% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $1.5M | $607.5K | $0 | $3.0M |
| Cost of Revenue | $2.7M | - | - | - | - | - | - | - | - | $1.5M | $352.7K | $0 | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | -$58.5K | $254.8K | $0 | - |
| SG&A Expense | $132.1M | $105.9M | $13.5M | $9.8M | $10.8M | $8.8M | $6.9M | $6.6M | $6.6M | $6.1M | $6.1M | $2.7M | $1.5M |
| R&D Expense | $40.6M | $78.6M | $25.2M | $15.3M | $21.5M | $23.2M | $16.3M | $7.2M | $3.1M | $2.2M | $4.5M | $2.2M | $2.4M |
| Operating Income | $9.4M | -$187.7M | -$41.4M | -$24.4M | -$31.5M | -$36.3M | -$23.5M | -$14.3M | -$12.2M | -$8.3M | -$12.2M | -$5.2M | -$846.8K |
| Interest Expense | $5.5M | $231.0K | - | - | - | - | - | - | - | - | $0 | $4.1M | $2.9M |
| Income Tax | $0 | $0 | $0 | - | - | - | - | $0 | -$1.6M | $0 | $0 | $0 | $0 |
| Net Income | $20.9M | -$175.8M | -$39.0M | -$24.1M | -$30.9M | -$24.6M | -$30.8M | -$13.3M | -$15.4M | -$12.1M | -$15.9M | -$13.2M | -$3.7M |
| EPS (Basic) | $0.40 | -$4.38 | -$2.36 | -$2.87 | -$5.81 | - | - | - | - | - | - | - | - |
| EPS (Diluted) | $0.39 | -$4.38 | -$2.36 | -$2.87 | -$5.81 | - | - | - | - | -$1.69 | -$10.42 | -$6.92 | - |
| Shares Outstanding | 52.4M | 40.2M | 16.5M | 8.4M | 5.3M | 62.6M | 34.1M | 21.0M | 9.0M | 14.0M | 6.8M | 535.7K | 535.6K |
| Gross Margin | - | - | - | - | - | - | - | - | - | -4.0% | 41.9% | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | -573.8% | -2001.7% | - | -28.2% |
| Profit Margin | - | - | - | - | - | - | - | - | - | -831.6% | -2618.8% | - | -123.6% |